IL6 and type 2 diabetes mellitus: First, it increases circulating levels of pro-inflammatory cytokines, such as IL-6 and C-reactive protein, which promote chronic systemic inflammation—a key pathophysiological feature and pathogenic mechanism of T2DM [9,40,41].